721 related articles for article (PubMed ID: 23662653)
1. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
Bentley MJ; Wilson AR; Rodgers GM
Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
3. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange.
Bentley MJ; Lehman CM; Blaylock RC; Wilson AR; Rodgers GM
Transfusion; 2010 Aug; 50(8):1654-64. PubMed ID: 20412532
[TBL] [Abstract][Full Text] [Related]
4. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
5. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
Vesely SK; George JN; Lämmle B; Studt JD; Alberio L; El-Harake MA; Raskob GE
Blood; 2003 Jul; 102(1):60-8. PubMed ID: 12637323
[TBL] [Abstract][Full Text] [Related]
7. Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.
Barrows BD; Teruya J
Arch Pathol Lab Med; 2014 Apr; 138(4):546-9. PubMed ID: 24678685
[TBL] [Abstract][Full Text] [Related]
8. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
9. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
11. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
[TBL] [Abstract][Full Text] [Related]
12. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
[TBL] [Abstract][Full Text] [Related]
13. Clinical study on five cases of thrombotic thrombocytopenic purpura complicating pregnancy.
He Y; Chen Y; Zhao Y; Zhang Y; Yang W
Aust N Z J Obstet Gynaecol; 2010 Dec; 50(6):519-22. PubMed ID: 21133861
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
15. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
16. Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Expert Opin Pharmacother; 2007 Mar; 8(4):437-44. PubMed ID: 17309338
[TBL] [Abstract][Full Text] [Related]
17. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada.
Wynick C; Britto J; Sawler D; Parker A; Karkhaneh M; Goodyear MD; Sun HL
Thromb Res; 2020 Dec; 196():335-339. PubMed ID: 32977133
[TBL] [Abstract][Full Text] [Related]
18. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT; Cheves T; Sweeney JD
Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
[TBL] [Abstract][Full Text] [Related]
19. Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpura.
Raval JS; Harm SK; Rollins-Raval MA; Kiss JE
J Clin Apher; 2014 Apr; 29(2):113-9. PubMed ID: 24123112
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
